Atlas Trials

Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD

Clinical trial NCT04930445 · TERMINATED

Trial details

NCT number
NCT04930445
Sponsor
Pfizer
Status
TERMINATED
Study type
OBSERVATIONAL
Sickle Cell Disease
Start date
2022-02-04
Primary completion
2024-10-10
Enrollment
265

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.